Follow the people · Insider
Jonathan Allan
Jonathan Allan files insider transactions with the SEC as a general counsel & corp sec of Stoke Therapeutics (STOK). We hold 5 disclosed purchases and sales filed since 17 March 2023, 2 of them in the last 90 days.
- Files forSTOK
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 March 2023 — 18 August 2026General Counsel & Corp Sec · Stoke Therapeutics (STOK)97 Form 4 lines · source: SEC Form 4
Everything they disclosed
97 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 418 August 2026Common Stock · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 2,716 shares of Stoke TherapeuticsSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- ▼ sold on the open market 145 shares of Stoke TherapeuticsSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 August 2026Performance Stock Units · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 1,457 shares of Stoke TherapeuticsSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 8,692 shares of Stoke TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- ▼ sold on the open market 601 shares of Stoke TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- ▼ sold on the open market 8,692 shares of Stoke TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- ▼ sold on the open market 601 shares of Stoke TherapeuticsSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- ▼ sold on the open market 2,476 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 1,791 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 4,222 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 334 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 72 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 2,476 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 1,791 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 4,222 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 334 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 72 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- exercised options over 7,475 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 12,000 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,475 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 12,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,475 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 12,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 7,475 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 12,000 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 53,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Employee Stock Option (Right to Buy) · traded 17 February 2026 · filed 19 February 2026
- was granted 35,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Restricted Stock Units · traded 17 February 2026 · filed 19 February 2026
- was granted 53,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Employee Stock Option (Right to Buy) · traded 17 February 2026 · filed 19 February 2026
- was granted 35,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Restricted Stock Units · traded 17 February 2026 · filed 19 February 2026
- ▼ sold on the open market 1,300 shares of Stoke TherapeuticsSEC Form 410 December 2025Common Stock · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 2,678 shares of Stoke TherapeuticsSEC Form 410 December 2025Common Stock · traded 8 December 2025 · filed 10 December 2025
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2025Performance Stock Units · traded 3 December 2025 · filed 5 December 2025
- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 3 December 2025 · filed 5 December 2025
- ▼ sold on the open market 824 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 4 December 2025 · filed 5 December 2025
- ▼ sold on the open market 194 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 4 December 2025 · filed 5 December 2025
- ▼ sold on the open market 1,004 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 5 December 2025 · filed 5 December 2025
- ▼ sold on the open market 5,437 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 5 December 2025 · filed 5 December 2025
- ▼ sold on the open market 2,344 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 5 December 2025 · filed 5 December 2025
- exercised options over 12,357 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 December 2025Restricted Stock Units · traded 1 December 2025 · filed 3 December 2025
- exercised options over 12,357 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- ▼ sold on the open market 1,416 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 868 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 898 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 3 December 2025 · filed 3 December 2025
- ▼ sold on the open market 1,394 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 3 December 2025 · filed 3 December 2025
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 47 October 2025Stock Option (Right to Buy) · traded 3 October 2025 · filed 7 October 2025
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 47 October 2025Common Stock · traded 3 October 2025 · filed 7 October 2025
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 47 October 2025Common Stock · traded 3 October 2025 · filed 7 October 2025
- exercised options over 850 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 29 August 2025 · filed 3 September 2025
- exercised options over 9,150 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 September 2025Stock Option (Right to Buy) · traded 2 September 2025 · filed 3 September 2025
- exercised options over 850 shares of Stoke TherapeuticsSEC Form 43 September 2025Common Stock · traded 29 August 2025 · filed 3 September 2025
- ▼ sold on the open market 850 shares of Stoke TherapeuticsSEC Form 43 September 2025Common Stock · traded 29 August 2025 · filed 3 September 2025
- exercised options over 9,150 shares of Stoke TherapeuticsSEC Form 43 September 2025Common Stock · traded 2 September 2025 · filed 3 September 2025
- ▼ sold on the open market 14,922 shares of Stoke TherapeuticsSEC Form 43 September 2025Common Stock · traded 2 September 2025 · filed 3 September 2025
- ▼ sold on the open market 6,345 shares of Stoke TherapeuticsSEC Form 43 September 2025Common Stock · traded 3 September 2025 · filed 3 September 2025
- ▼ sold on the open market 1,683 shares of Stoke TherapeuticsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- was granted 12,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 August 2025Performance Stock Units · traded 14 August 2025 · filed 18 August 2025
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 August 2025Performance Stock Units · traded 14 August 2025 · filed 18 August 2025
- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 418 August 2025Common Stock · traded 14 August 2025 · filed 18 August 2025
- ▼ sold on the open market 13,712 shares of Stoke TherapeuticsSEC Form 415 August 2025Common Stock · traded 13 August 2025 · filed 15 August 2025
- was granted 72,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 420 March 2025Employee Stock Option (Right to Buy) · traded 20 March 2025 · filed 20 March 2025
- was granted 48,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 420 March 2025Restricted Stock Units · traded 20 March 2025 · filed 20 March 2025
- ▼ sold on the open market 2,266 shares of Stoke TherapeuticsSEC Form 420 March 2025Common Stock · traded 18 March 2025 · filed 20 March 2025
- ▼ sold on the open market 1,945 shares of Stoke TherapeuticsSEC Form 420 March 2025Common Stock · traded 19 March 2025 · filed 20 March 2025
- exercised options over 7,475 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 7,475 shares of Stoke TherapeuticsSEC Form 418 March 2025Common Stock · traded 15 March 2025 · filed 18 March 2025
- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 418 March 2025Common Stock · traded 15 March 2025 · filed 18 March 2025
- ▼ sold on the open market 12,114 shares of Stoke TherapeuticsSEC Form 411 December 2024Common Stock · traded 9 December 2024 · filed 11 December 2024
- ▼ sold on the open market 1,552 shares of Stoke TherapeuticsSEC Form 411 December 2024Common Stock · traded 9 December 2024 · filed 11 December 2024
- ▼ sold on the open market 9,696 shares of Stoke TherapeuticsSEC Form 410 December 2024Common Stock · traded 6 December 2024 · filed 10 December 2024
- was granted 12,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2024Performance Stock Units · traded 3 December 2024 · filed 5 December 2024
- exercised options over 6,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2024Performance Stock Units · traded 3 December 2024 · filed 5 December 2024
- exercised options over 6,000 shares of Stoke TherapeuticsSEC Form 45 December 2024Common Stock · traded 3 December 2024 · filed 5 December 2024
- exercised options over 33,927 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 December 2024Restricted Stock Unit (RSU) · traded 1 December 2024 · filed 3 December 2024
- exercised options over 33,927 shares of Stoke TherapeuticsSEC Form 43 December 2024Common Stock · traded 1 December 2024 · filed 3 December 2024
- was granted 36,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 47 June 2024Employee Stock Option (Right to Buy) · traded 27 March 2024 · filed 7 June 2024
- was granted 24,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 47 June 2024Restricted Stock Units · traded 27 March 2024 · filed 7 June 2024
- exercised options over 8,599 shares of Stoke Therapeutics (a derivative holding)SEC Form 422 May 2024Stock Option (Right to Buy) · traded 20 May 2024 · filed 22 May 2024
- exercised options over 8,599 shares of Stoke TherapeuticsSEC Form 422 May 2024Common Stock · traded 20 May 2024 · filed 22 May 2024
- ▼ sold on the open market 8,599 shares of Stoke TherapeuticsSEC Form 422 May 2024Common Stock · traded 20 May 2024 · filed 22 May 2024
- ▼ sold on the open market 5,026 shares of Stoke TherapeuticsSEC Form 41 April 2024Common Stock · traded 28 March 2024 · filed 1 April 2024
- ▼ sold on the open market 100 shares of Stoke TherapeuticsSEC Form 41 April 2024Common Stock · traded 28 March 2024 · filed 1 April 2024
- exercised options over 7,475 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 March 2024Restricted Stock Units · traded 15 March 2024 · filed 19 March 2024
- exercised options over 7,475 shares of Stoke TherapeuticsSEC Form 419 March 2024Common Stock · traded 15 March 2024 · filed 19 March 2024
- ▼ sold on the open market 2,349 shares of Stoke TherapeuticsSEC Form 419 March 2024Common Stock · traded 19 March 2024 · filed 19 March 2024
- returned to the issuer 65,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2023Employee Stock Option (Right to Buy) · traded 1 December 2023 · filed 5 December 2023
- returned to the issuer 121,100 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2023Employee Stock Option (Right to Buy) · traded 1 December 2023 · filed 5 December 2023
- was granted 46,284 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2023Restricted Stock Unit (RSU) · traded 1 December 2023 · filed 5 December 2023
- ▼ sold on the open market 1,948 shares of Stoke TherapeuticsSEC Form 423 June 2023Common Stock · traded 21 June 2023 · filed 23 June 2023
- was granted 44,800 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2023Employee Stock Option (Right to Buy) · traded 15 March 2023 · filed 17 March 2023
- was granted 29,900 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2023Restricted Stock Unit (RSU) · traded 15 March 2023 · filed 17 March 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.